ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6.12	13.29	12.6	5.88	16.94
Short-Term Investments	0.03	0.03	0.03	0.04	0.04
Cash & Short-Term Investments	6.15	13.32	12.63	5.92	16.98
Cash Growth	-53.84%	5.49%	113.36%	-65.14%	1857.25%
Other Receivables	-	0.08	0.08	0.07	0.05
Receivables	-	0.08	0.08	0.07	0.05
Prepaid Expenses	3.03	0.37	0.53	0.56	0.12
Other Current Assets	-	5.13	0.38	0.35	0.56
Total Current Assets	9.18	18.91	13.62	6.9	17.71
Property, Plant & Equipment	-	-	-	0	0
Other Intangible Assets	-	-	-	0.02	0.03
Total Assets	9.18	18.91	13.62	6.92	17.75
Accounts Payable	2.54	1.74	7.84	2.98	0.41
Accrued Expenses	7.87	0.48	1.51	3.44	0.52
Total Current Liabilities	10.41	2.22	9.35	6.41	0.93
Long-Term Debt	-	-	-	-	3.91
Other Long-Term Liabilities	0.03	0.2	0.52	1.86	7.25
Total Liabilities	10.44	2.42	9.87	8.27	12.09
Additional Paid-In Capital	129.52	107.55	97.59	79.1	68.04
Retained Earnings	-130.41	-90.69	-93.47	-80.25	-62.19
Comprehensive Income & Other	-0.37	-0.37	-0.37	-0.2	-0.19
Shareholders' Equity	-1.26	16.49	3.75	-1.35	5.66
Total Liabilities & Equity	9.18	18.91	13.62	6.92	17.75
Total Debt	-	-	-	-	3.91
Net Cash (Debt)	6.15	13.32	12.63	5.92	13.08
Net Cash Growth	-53.84%	5.49%	113.36%	-54.73%	1407.11%
Net Cash Per Share	3.50	12.59	25.69	19.73	56.51
Filing Date Shares Outstanding	2.15	1.31	0.76	0.34	0.29
Total Common Shares Outstanding	2.15	1.31	0.76	0.34	0.29
Working Capital	-1.23	16.69	4.27	0.49	16.79
Book Value Per Share	-0.58	12.61	4.97	-3.93	19.67
Tangible Book Value	-1.26	16.49	3.75	-1.37	5.63
Tangible Book Value Per Share	-0.58	12.61	4.97	-3.99	19.57
Machinery	-	-	-	-	0.08

Updated Mar 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q